Cardiac Biomarker of Choice for diagnosis of Re-infarction 8 days after the initial ischemic event is:
**Core Concept**
The diagnosis of re-infarction after an initial ischemic event involves the detection of elevated levels of cardiac biomarkers in the blood. Among these biomarkers, troponin is highly specific for cardiac muscle damage and is widely used for the diagnosis of acute myocardial infarction (AMI).
**Why the Correct Answer is Right**
Troponin T (TnT) and Troponin I (TnI) are the preferred cardiac biomarkers for the diagnosis of re-infarction due to their high sensitivity and specificity for cardiac muscle damage. Elevated levels of TnT or TnI in the blood indicate damage to the cardiac muscle, which can occur during a re-infarction. The half-life of troponin T is approximately 3-5 days, allowing for the detection of re-infarction even after 8 days from the initial ischemic event.
**Why Each Wrong Option is Incorrect**
* **Option A:** Creatine kinase (CK) is a cardiac biomarker, but it is less specific for cardiac muscle damage compared to troponin. CK can be elevated in other conditions such as skeletal muscle damage or renal failure.
* **Option B:** Myoglobin is a small protein that is released into the bloodstream from damaged cardiac muscle. However, it lacks specificity and can be elevated in other conditions such as muscle crush injuries or renal failure.
* **Option C:** Lactate dehydrogenase (LDH) is an enzyme found in many body tissues, including the heart. However, it is not specific for cardiac muscle damage and can be elevated in other conditions such as liver disease or hemolysis.
**Clinical Pearl / High-Yield Fact**
When diagnosing re-infarction, it is essential to consider the timing and pattern of troponin elevation. A rise in troponin levels over 6-12 hours, or a new peak troponin level above the previous one, supports the diagnosis of re-infarction.
**Correct Answer:** C. Troponin T (TnT) and Troponin I (TnI) are the preferred cardiac biomarkers for the diagnosis of re-infarction.